batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Syndax gets an early menin nod 18 November 2024 Another makeover for Halozyme? 15 November 2024 Not so fast for Astra in bladder cancer 14 November 2024 A second sarcoma success for Adaptimmune 13 November 2024 The end looms for Syros 13 November 2024 Astra shifts its dato lung focus again 12 November 2024 Merck KGaA gets a rare cancer win 12 November 2024 Ideaya pushes on with a dual ADC approach 11 November 2024 Load More